These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12148883

  • 1. Early-stage idiopathic (primary) myelofibrosis--current issues of diagnostic features.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Leuk Lymphoma; 2002 May; 43(5):1035-41. PubMed ID: 12148883
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
    Michiels JJ, Kutti J, Stark P, Bazzan M, Gugliotta L, Marchioli R, Griesshammer M, van Genderen PJ, Brière J, Kiladjian JJ, Barbui T, Finazzi G, Berlin NI, Pearson TC, Green AC, Fruchtmann SM, Silver RT, Hansmann E, Wehmeier A, Lengfelder E, Landolfi R, Kvasnicka HM, Hasselbalch H, Cervantes F, Thiele J.
    Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
    [Abstract] [Full Text] [Related]

  • 3. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
    Thiele J, Kvasnicka HM, Boeltken B, Zankovich R, Diehl V, Fischer R.
    Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
    [Abstract] [Full Text] [Related]

  • 6. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ, Thiele J.
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [Abstract] [Full Text] [Related]

  • 7. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM.
    Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
    [Abstract] [Full Text] [Related]

  • 8. Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Zankovich R, Diehl V.
    Am J Hematol; 2002 Aug; 70(4):283-91. PubMed ID: 12210809
    [Abstract] [Full Text] [Related]

  • 9. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W.
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hematopathologic findings in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM.
    Semin Oncol; 2005 Aug; 32(4):380-94. PubMed ID: 16202684
    [Abstract] [Full Text] [Related]

  • 13. Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.
    Marcinek J, Plank L, Szépe P, Balhárek T.
    Cesk Patol; 2008 Jul; 44(3):62-6. PubMed ID: 18783136
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
    Michiels JJ.
    Hematol J; 2004 Jul; 5(2):93-102. PubMed ID: 15048058
    [Abstract] [Full Text] [Related]

  • 15. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J, Kvasnicka HM.
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [Abstract] [Full Text] [Related]

  • 16. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J, Zankovich R, Steinberg T, Kremer B, Fischer R, Diehl V.
    Acta Haematol; 1989 Mar; 81(4):192-202. PubMed ID: 2474228
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.
    Thiele J, Kvasnicka HM, Diehl V, Fischer R, Michiels J.
    Leuk Lymphoma; 1999 Apr; 33(3-4):207-18. PubMed ID: 10221501
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features--a clinicopathological study on 272 patients.
    Thiele J, Kvasnicka HM.
    Histol Histopathol; 2003 Jan; 18(1):93-102. PubMed ID: 12507288
    [Abstract] [Full Text] [Related]

  • 19. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V.
    Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
    [Abstract] [Full Text] [Related]

  • 20. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J, Kvasnicka HM.
    Pathobiology; 2007 Jan; 74(2):89-96. PubMed ID: 17587880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.